Researchers have begun investigating the use of a tuberculosis vaccine in the fight against COVID-19.
Trials of the vaccine, Bacillus Calmette-Guérin, or BCG, are currently underway in the Netherlands and Australia.
According to UPI, additional studies are scheduled to start in Africa in the coming weeks.
The well-known vaccine has been used since the1920s and is in high demand across the globe.
